Chemoinformaics analysis of Desmethylxanthohumol
Molecular Weight | 340.375 | nRot | 5 |
Heavy Atom Molecular Weight | 320.215 | nRig | 15 |
Exact Molecular Weight | 340.131 | nRing | 2 |
Solubility: LogS | -3.356 | nHRing | 0 |
Solubility: LogP | 4.85 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 5 | No. of Arom Bond | 12 |
nHA | 5 | APOL | 50.7459 |
nHD | 4 | BPOL | 20.9321 |
QED | 0.376 |
Synth | 2.661 |
Natural Product Likeliness | 1.671 |
NR-PPAR-gamma | 0.951 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.017 |
Pgp-sub | 0.094 |
HIA | 0.009 |
CACO-2 | -5.055 |
MDCK | 0.0000145 |
BBB | 0.01 |
PPB | 1.00656 |
VDSS | 0.619 |
FU | 0.00883958 |
CYP1A2-inh | 0.95 |
CYP1A2-sub | 0.132 |
CYP2c19-inh | 0.809 |
CYP2c19-sub | 0.056 |
CYP2c9-inh | 0.825 |
CYP2c9-sub | 0.863 |
CYP2d6-inh | 0.87 |
CYP2d6-sub | 0.541 |
CYP3a4-inh | 0.541 |
CYP3a4-sub | 0.154 |
CL | 14.501 |
T12 | 0.85 |
hERG | 0.045 |
Ames | 0.679 |
ROA | 0.618 |
SkinSen | 0.952 |
Carcinogencity | 0.533 |
EI | 0.907 |
Respiratory | 0.425 |
NR-Aromatase | 0.862 |
Antiviral | Yes |
Prediction | 0.724687 |